falsefalse

My Treatment Approach: Modern Perspectives on the Management of Chronic Phase CML (CP-CML) - Episode 1

The Impact of Patient Comorbidities on Frontline Treatment Selection and Assessing the Different Frontline Treatment Options for Chronic Phase CML (CP-CML)

Drs. Elias Jabbour and Michael Mauro discuss how patient comorbidities influence the selection of frontline tyrosine kinase inhibitor (TKI) therapy in chronic phase CML, highlighting specific comorbidity-TKI combinations to avoid and strategies for optimizing individualized treatment.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    x